 | • レポートコード：B-MOR-08466 • 出版社/出版日：Mordor Intelligence / 2018年5月1日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・製薬 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ポジトロン断層法の世界市場について調べ、ポジトロン断層法の世界規模、市場動向、市場環境、製品種類別（フルリングPETスキャナー、パーシャルリングPETスキャナー）分析、用途別（心臓病学、神経学、腫瘍学、その他）分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・ポジトロン断層法の世界市場インサイト ・ポジトロン断層法の世界市場環境 ・ポジトロン断層法の世界市場動向 ・ポジトロン断層法の世界市場規模 ・ポジトロン断層法の世界市場規模：製品種類別（フルリングPETスキャナー、パーシャルリングPETスキャナー） ・ポジトロン断層法の世界市場規模：用途別（心臓病学、神経学、腫瘍学、その他） ・ポジトロン断層法の世界市場規模：エンドユーザー別 ・ポジトロン断層法の世界市場：地域別市場規模・分析 ・ポジトロン断層法の北米市場規模・予測 ・ポジトロン断層法のアメリカ市場規模・予測 ・ポジトロン断層法のヨーロッパ市場規模・予測 ・ポジトロン断層法のアジア市場規模・予測 ・ポジトロン断層法の日本市場規模・予測 ・ポジトロン断層法の中国市場規模・予測 ・ポジトロン断層法のインド市場規模・予測 ・ポジトロン断層法の韓国市場規模・予測 ・関連企業情報・競争状況 |
The positron emission tomography market is expected to register a CAGR of 5% during the forecast period, 2018 to 2023. North America dominates the market, due to growing incidence of cancer and technological advancement in the region.
Increasing Demand for PET Analysis in Radiopharmaceuticals
The technological advancements, like the Time of Flight (TOF) and the rise in popularity of hybrid imaging systems play an important role in the nuclear medicine market growth. The hybrid imaging, using combined scanners, such as PET, is offering a promising future to the nuclear medicine industry. The growing significance of the PET technology application in cardiac and neurological disorders is expected to fuel the growth of the global market. The advancements in various approaches for PET are expected to strengthen the personalized medicine industry, based on which, a continued growth is expected in the global positron emission tomography market, during the forecast period.
Short Half Life of Diagnostics Radioisotopes
Majority of the diagnostic radioisotopes have a short half-life, owing to which, they cannot be stored for long period and have to be used within a short period after production. For example, Technetium-99 is produced from a precursor radioisotope called Molybdenum-99. Molybdenum-99 has a half-life of 66 hours. Owing to its short life, Molybdenum-99 has to reach the end-user within 66 hours, and this includes the entire duration, from the time of production in the nuclear reactor to reaching the site of use, where it will be converted to Technetium-99. While Technetium-99 has a half-life of only 6.6 hours and has to be used within this time. This pricing by the supplier results in higher price of radioisotopes. In addition, given the nature of radioisotopes, there is currently no possible way to address the issue of radioisotopes short half-life. Therefore, short half-life of radioisotopes coupled with the stringent regulatory policies is hindering the growth of the global positron emission tomography market.
North America to Show Tremendous Growth
North America dominates the positron emission tomography market, owing to high demand for precision diagnostics and technological advancement in PET technology in the region. Asia Pacific is expected to grow during the forecast period, owing to factors, such as high prevalence of cancer, growing awareness regarding early diagnosis, less stringent regulatory scenario, and presence of huge population base.
Key Developments in the Market
• December 2017: Conemaugh Memorial Medical Center has invested in new PET/CT technology that benefits patients by providing a high quality image in half the time with half the radiation. PET-CT stands for Positron Emission Tomography and Computer Tomography scans
Major Players: PHILIPS HEALTHCARE, SIEMENS, POSITRON CORPORATION, AGFA HEALTHCARE, NEUSOFT MEDICAL SYSTEMS, GAMMA MEDICA INC., GE HEALTHCARE, ONCOVISION BOSTON SCIENTIFIC, SYNCHROPET, ZECOTEK PHOTONICS, BRAIN BIOSCIENCES, AND RAY VISION INTL, amongst others.
Reasons to Purchase this Report
• Current and future positron emission tomography market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Demand For PET Analysis In Radiopharmaceuticals
6.1.2 Technological Advancements In Pet Imaging For Oncology And Advanced Diagnostics Applications
6.1.3 Integration Of X-Ray Tomography (CT) Into PET
6.1.4 Others
6.2 Market Restraints
6.2.1 Shorter Half-Life Of Radioisotopes
6.2.2 Stringent Regulatory Guidelines
6.2.3 Others
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product Type
7.1.1 Full Ring PET Scanners
7.1.2 Partial Ring PET Scanners
7.2 By Applications
7.2.1 Cardiology
7.2.2 Neurology
7.2.3 Oncology
7.2.4 Others
7.3 By End-users
7.3.1 Hospitals
7.3.2 Diagnostic Centers
7.3.3 Others
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United Kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe
7.4.3 Asia-Pacific
7.4.3.1 China
7.4.3.2 Japan
7.4.3.3 India
7.4.3.4 Australia & New Zealand
7.4.3.5 South Korea
7.4.3.6 Rest of Asia-Pacific
7.4.4 Middle East & Africa
7.4.4.1 GCC
7.4.4.2 South Africa
7.4.4.3 Rest of the Middle East & Africa
7.4.5 South America
7.4.5.1 Brazil
7.4.5.2 Argentina
7.4.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Agfa Healthcare
9.2 Gamma Medica Inc.
9.3 GE Healthcare
9.4 Neusoft Medical Systems
9.5 Oncovision
9.6 Koninklijke Philips N.V.
9.7 Positron Corporation
9.8 Siemens AG
9.9 List Not Exhaustive
10. Future of the Market